{"id":12029,"date":"2008-02-05T16:50:00","date_gmt":"2008-02-05T15:50:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/fda-pericolo-da-farmaci-contro-lepilessia\/"},"modified":"2008-02-05T16:50:00","modified_gmt":"2008-02-05T15:50:00","slug":"fda-pericolo-da-farmaci-contro-lepilessia","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/fda-pericolo-da-farmaci-contro-lepilessia\/","title":{"rendered":"FDA: DANGER FROM EPILEPSY DRUGS"},"content":{"rendered":"<p> <strong><font size=\"2\">There is a new alarm in the USA for medicines used to fight epilepsy. According to the Food and Drug Administration, according to which <font size=\"3\">those who use them run the risk of committing suicide.<\/font>More than 200 studies have been carried out since 2005 up to today <font size=\"3\">11 drugs<\/font>, some of these used in the treatment of migraines or nervous disorders, for years on the market, widely consumed.<br \/> Patients analyzed and treated with these drugs were <font size=\"3\">28 thousand,<\/font> 16,000 were instead subjected to treatment with neutral drugs, used to induce the placebo effect.<br \/> These are the results achieved: only 4 cases of suicide, even if the patients who had suicidal thoughts were double (0.43%) compared to those treated with &quot;placebo&quot; pills (0.22%). Given the percentages, the FDA has concluded that for every thousand patients, two have had the temptation to commit suicide. <br \/> <font size=\"3\">All the drugs examined are accused: Pfizer Inc. (PFE)&#039;s Neurontin, Novartis AG&#039; (NVS)&#039;s Tegretol, Abbott Laboratories&#039; (ABI) Depakote.<\/font>&nbsp; Farmacia.it dated 04\/02\/2008<\/font><\/strong>&nbsp;&nbsp;&nbsp;&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>E&#8217; di nuovo allarme in Usa per i medicinali utilizzati per combattere l&#8217;epilessia. A darlo la Food and Drug Administration , secondo cui chi li usa corre il rischio di arrivare al suicidio.Sono stati pi&ugrave; di 200 gli studi portati avanti dal 2005 ad oggi su 11 farmaci, alcuni di questi impiegati nel trattamento delle &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-12029","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=12029"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12029\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=12029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=12029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=12029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}